Streetbeat News

Stock Prices

SNOW

Snowflake Inc (NYSE:SNOW) reported strong Q3 results, surpassing consensus estimates for revenues and earnings, leading to 9 out of 10 analysts raising their price targets. The company's product revenue guidance for fiscal 2024 was raised to $2.65 billion due to improving consumption trends. Analysts highlighted the company's high net revenue retention, new customer additions, large-customer traction, and the potential impact of new products and GenAI on future growth. Shares of Snowflake rose by 4.30% to $183.30 following the earnings release.

Portfolio Pulse from Priya Nigam

November 30, 2023 | 5:37 pm

AXP

JPM

MTB

SCHW

SYF

TFC

WFC

Benzinga's options activity scanner has detected notable whale activity in the Financials sector, involving large trades in options for TFC, WFC, JPM, SYF, GS, MTB, AX, SQ, SCHW, and AXP. The trades include a mix of bullish, bearish, and neutral sentiments, with varying expiration dates and strike prices. The total trade prices ranged from $27.1K to $672.0K, indicating significant market transactions that could influence the short-term price movements of these stocks.

Portfolio Pulse from Benzinga Insights

November 30, 2023 | 5:35 pm

AREN

ASST

BREA

CTV

CURI

LIZI

MNY

NCTY

QNST

SST

In Thursday's intraday session, several communication services stocks experienced significant movements. System1 (SST) saw a 15.9% increase, while Arena Group Holdings (AREN) rose by 15.46%. Brera Holdings (BREA) and The9 (NCTY) also saw their stocks go up by 14.32% and 13.82%, respectively. Innovid (CTV) and QuinStreet (QNST) shares increased by 11.74% and 10.45%. On the downside, Lizhi (LIZI) dropped by 26.6% following its Q3 earnings report. MoneyHero (MNY), Zhihu (ZH), Asset Entities (ASST), Weibo (WB), and CuriosityStream (CURI) also saw their stocks decline by 23.69%, 16.44%, 14.25%, 12.99%, and 10.59%, respectively.

Portfolio Pulse from Benzinga Insights

November 30, 2023 | 5:31 pm

AMPE

COCH

CYTO

IMGN

LMDX

NBSE

OSA

RDHL

RNAZ

SNGX

VVOS

ZVSA

In Thursday's intraday session, several healthcare stocks experienced significant movements. Soligenix (SNGX) saw a dramatic increase of 249.1%, while Immunogen (IMGN) rose by 82.31%. Other gainers included Ampio Pharmaceuticals (AMPE), TransCode Therapeutics (RNAZ), LumiraDx (LMDX), and NeuBase Therapeutics (NBSE). Conversely, Vivos Therapeutics (VVOS) led the losers with a 40.5% drop, followed by declines in Altamira Therapeutics (CYTO), Redhill Biopharma (RDHL), Envoy Medical (COCH), ProSomnus (OSA), and ZyVersa Therapeutics (ZVSA).

Portfolio Pulse from Benzinga Insights

November 30, 2023 | 5:31 pm

AIRTP

ESGL

PIXY

VIEW

During Thursday's intraday session, several industrial stocks experienced significant movements. ShiftPixy (PIXY) saw a 33.1% increase, while ESGL Holdings (ESGL) dropped by 30.4%. Other notable gainers included Air T (AIRTP), Singularity Future Tech (SGLY), Recruiter.Com Group (RCRT), Li-Cycle Holdings (LICY), and 1847 Holdings (EFSH). On the losing side, View (VIEW), BioNexus Gene Lab (BGLC), Fusion Fuel Green (HTOO), iSun (ISUN), and Applied UV (AUVI) saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

November 30, 2023 | 5:31 pm

BKYI

FOXO

FSLY

LAES

LEDS

MINM

NSYS

NVNI

PBTS

PSTG

QUIK

SGE

In Thursday's intraday session, several information technology stocks experienced significant movements. Minim (MINM) saw a dramatic increase of 572.4% to $6.12, while SemiLEDs (LEDS), Strong Global (SGE), Powerbridge Technologies (PBTS), Nortech Systems (NSYS), and BIO-key Intl (BKYI) also posted gains. Conversely, Nvni Group (NVNI), Pure Storage (PSTG), FOXO Technologies (FOXO), SEALSQ (LAES), Fastly (FSLY), and QuickLogic (QUIK) experienced declines, with PSTG notably dropping after its Q3 earnings release.

Portfolio Pulse from Benzinga Insights

November 30, 2023 | 5:30 pm

CRM

Oppenheimer analyst Brian Schwartz has maintained an Outperform rating on Salesforce (NYSE:CRM) and increased the price target from $250 to $275. This adjustment reflects a positive outlook on the company's performance and potential growth.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 5:27 pm

DBGI

Digital Brands Group (DBGI) shares have resumed trading. There is no additional context provided regarding why trading was halted or what circumstances led to the resumption.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 5:27 pm

XENE

Xenon Pharmaceuticals has announced the pricing of its upsized public offering of 8,461,542 common shares at $32.50 per share, raising $300 million. Shares are trading higher following the news.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 5:25 pm

DIS

Nelson Peltz and Trian Fund Management are seeking to obtain more than two seats on Disney's board, hinting at a possible proxy fight. Disney is aiming for $7.5 billion in cost savings and views the move as potentially motivated by a personal vendetta from Ike Perlmutter, a former executive. Despite restructuring efforts and cost-saving targets, Disney declined Trian's offer for board inclusion. Disney's stock (DIS) saw a slight increase of 0.06% to $92.56.

Portfolio Pulse from Vandana Singh

November 30, 2023 | 5:25 pm